APA (7th ed.) Citation

Lipton, R. B., Grosberg, B., Singer, R. P., Pearlman, S. H., Sorrentino, J. V., Quiring, J. N., & Saper, J. R. (2010). Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia, 30(11), 1336-1345. https://doi.org/10.1177/0333102410367523

Chicago Style (17th ed.) Citation

Lipton, Richard B., Brian Grosberg, Richard P. Singer, Starr H. Pearlman, James V. Sorrentino, John N. Quiring, and Joel R. Saper. "Efficacy and Tolerability of a New Powdered Formulation of Diclofenac Potassium for Oral Solution for the Acute Treatment of Migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)." Cephalalgia 30, no. 11 (2010): 1336-1345. https://doi.org/10.1177/0333102410367523.

MLA (9th ed.) Citation

Lipton, Richard B., et al. "Efficacy and Tolerability of a New Powdered Formulation of Diclofenac Potassium for Oral Solution for the Acute Treatment of Migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)." Cephalalgia, vol. 30, no. 11, 2010, pp. 1336-1345, https://doi.org/10.1177/0333102410367523.